Dawn F. Ionescu, M.D.
Dawn F. Ionescu, M.D.
Director, Neuroscience Clinical Development, Janssen Pharmaceuticals
Verified email at its.jnj.com
Title
Cited by
Cited by
Year
Improvement in suicidal ideation after ketamine infusion: relationship to reductions in depression and anxiety
ED Ballard, DF Ionescu, JLV Voort, MJ Niciu, EM Richards, ...
Journal of psychiatric research 58, 161-166, 2014
1672014
Do the dissociative side effects of ketamine mediate its antidepressant effects?
DA Luckenbaugh, MJ Niciu, DF Ionescu, NM Nolan, EM Richards, ...
Journal of affective disorders 159, 56-61, 2014
1612014
Glutamate and its receptors in the pathophysiology and treatment of major depressive disorder
MJ Niciu, DF Ionescu, EM Richards, CA Zarate
Journal of neural transmission 121 (8), 907-924, 2014
1152014
Double-blind, placebo-controlled, dose-ranging trial of intravenous ketamine as adjunctive therapy in treatment-resistant depression (TRD)
M Fava, MP Freeman, M Flynn, H Judge, BB Hoeppner, C Cusin, ...
Molecular psychiatry 25 (7), 1592-1603, 2020
1012020
Neurobiology of anxious depression: a review
DF Ionescu, MJ Niciu, DC Mathews, EM Richards, CA Zarate Jr
Depression and anxiety 30 (4), 374-385, 2013
922013
Clinical predictors of ketamine response in treatment-resistant major depression
MJ Niciu, DA Luckenbaugh, DF Ionescu, S Guevara, R Machado-Vieira, ...
The Journal of clinical psychiatry 75 (5), e417, 2014
912014
Towards new mechanisms: an update on therapeutics for treatment-resistant major depressive disorder
GI Papakostas, DF Ionescu
Molecular psychiatry 20 (10), 1142-1150, 2015
892015
Effect of baseline anxious depression on initial and sustained antidepressant response to ketamine
DF Ionescu, DA Luckenbaugh, MJ Niciu, EM Richards, EE Slonena, ...
The Journal of clinical psychiatry 75 (9), 932-938, 2014
762014
Rapid and sustained reductions in current suicidal ideation following repeated doses of intravenous ketamine: secondary analysis of an open-label study
DF Ionescu, MB Swee, KJ Pavone, N Taylor, O Akeju, L Baer, M Nyer, ...
The Journal of clinical psychiatry 77 (6), 719-725, 2016
752016
Defining anxious depression: a review of the literature
DF Ionescu, MJ Niciu, ID Henter, CA Zarate Jr
CNS spectrums 18 (5), 252, 2013
752013
Pharmacological approaches to the challenge of treatment-resistant depression
DF Ionescu, JF Rosenbaum, JE Alpert
Dialogues in clinical neuroscience 17 (2), 111, 2015
742015
Classics in chemical neuroscience: ketamine
MW Tyler, HB Yourish, DF Ionescu, SJ Haggarty
ACS Chemical Neuroscience 8 (6), 1122-1134, 2017
622017
A single infusion of ketamine improves depression scores in patients with anxious bipolar depression
DF Ionescu, DA Luckenbaugh, MJ Niciu, EM Richards, CA Zarate Jr
Bipolar disorders 17 (4), 438-443, 2015
612015
Ketamine augmentation for outpatients with treatment-resistant depression: preliminary evidence for two-step intravenous dose escalation
C Cusin, DF Ionescu, KJ Pavone, O Akeju, P Cassano, N Taylor, ...
Australian & New Zealand Journal of Psychiatry 51 (1), 55-64, 2017
582017
Near-infrared transcranial radiation for major depressive disorder: proof of concept study
P Cassano, C Cusin, D Mischoulon, MR Hamblin, L De Taboada, A Pisoni, ...
Psychiatry journal 2015, 2015
522015
A randomized, placebo-controlled pilot trial of the delta opioid receptor agonist AZD2327 in anxious depression
EM Richards, DC Mathews, DA Luckenbaugh, DF Ionescu, ...
Psychopharmacology 233 (6), 1119-1130, 2016
492016
cAMP signaling in brain is decreased in unmedicated depressed patients and increased by treatment with a selective serotonin reuptake inhibitor
M Fujita, EM Richards, MJ Niciu, DF Ionescu, SS Zoghbi, J Hong, S Telu, ...
Molecular psychiatry 22 (5), 754-759, 2017
452017
Pharmacologic treatment of dimensional anxious depression: a review
DF Ionescu, MJ Niciu, EM Richards, CA Zarate Jr
The primary care companion for CNS disorders 16 (3), 2014
452014
Developing biomarkers in mood disorders research through the use of rapid‐acting antidepressants
MJ Niciu, DC Mathews, AC Nugent, DF Ionescu, ML Furey, EM Richards, ...
Depression and anxiety 31 (4), 297-307, 2014
442014
Repeat-dose ketamine augmentation for treatment-resistant depression with chronic suicidal ideation: a randomized, double blind, placebo controlled trial
DF Ionescu, KH Bentley, M Eikermann, N Taylor, O Akeju, MB Swee, ...
Journal of affective disorders 243, 516-524, 2019
392019
The system can't perform the operation now. Try again later.
Articles 1–20